Targeted therapies improve care for Demodex blepharitis and OSD
Timely diagnosis and personalized treatment are key to improving visual outcomes.
Timely diagnosis and personalized treatment are key to improving visual outcomes.
The prevalence and severity of refractive and corneal astigmatism in children rose after the COVID-19 pandemic, according to a study published in JAMA Ophthalmology.
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior segment eye care, artificial intelligence and clinical…
Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing reliance on low vision centers.
Reduced mental health is seen in patients with newly diagnosed glaucoma and certain anti–vascular endothelial growth factor (VEGF) agents for neovascular age-related macular degeneration (AMD)…
Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related macular degeneration, as highlighted at the 2025 International SPECTRALIS Symposium — And…
Patients diagnosed with primary open-angle glaucoma (POAG) may experience a measurable decline in self-reported mental health after learning about their disease, even in the absence…
In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the Johnson & Johnson Vision Tecnis…
This case report describes bilateral subconjunctival petechial hemorrhages in a man aged 28 years who tested positive for dengue virus infection.
To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and the latest AMD‐related GWAS summary data from the…